Anti-Obesity Medication Formulary UPDATES!!!

VERY EXCITING news from Dr. Bauer (Endocrinology Attending) regarding Anti-Obesity Medications and updated formulary list!

BLUF:

1. Starting 28AUG2024, Phentermine (and its analogs) will be on regular formulary and WILL NO LONGER NEED A PRIOR AUTHORIZATION (although a PA is not required the indication for prescribing it is the same: BMI≥30 or ≥27 w/ obesity related complication + in conjunction with lifestyle modifications).

2. Contrave, Qsymia, Wegovy, and Zepbound will now be in the same tier. This means the patient only requires failure/contraindication to phentermine prior to prescribing one of these 4 meds. So, based on clinical appropriateness, you can have your patients trial Phentermine, and if clinically indicated, can then go straight to Zepbound or Wegovy without them having to trial Qsymia and/or Contrave.

3. You no longer must continue to submit continuation Prior Auths.

4. See Peyton's email from 05AUG for more details.